American Century Companies
ESPR

American Century Companies’s Esperion Therapeutics ESPR Stock Holding History

American Century Companies’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,518
Closed -$50K – 2910
2024
Q2 		$50K Buy
+22,518
New +$53K ﹤0.01% 2861
2021
Q2 		– Sell
-9,111
Closed -$256K – 2308
2021
Q1 		$256K Sell
9,111
-976
-10% -$28.8K ﹤0.01% 1990
2020
Q4 		$262K Buy
+10,087
New +$302K ﹤0.01% 1773
2020
Q2 		– Sell
-31,655
Closed -$998K – 1750
2020
Q1 		$998K Buy
31,655
+943
+3% +$49.8K ﹤0.01% 986
2019
Q4 		$1.83M Sell
30,712
-48,133
-61% -$2.16M ﹤0.01% 966
2019
Q3 		$2.89M Buy
78,845
+18,596
+31% +$737K ﹤0.01% 909
2019
Q2 		$2.8M Buy
+60,249
New +$2.83M ﹤0.01% 967
2018
Q4 		– Sell
-52,544
Closed -$2.33M – 1266
2018
Q3 		$2.33M Buy
52,544
+23,769
+83% +$1.09M ﹤0.01% 1005
2018
Q2 		$1.13M Sell
28,775
-37
-0.1% -$1.87K ﹤0.01% 1090
2018
Q1 		$2.08M Buy
28,812
+4,445
+18% +$326K ﹤0.01% 992
2017
Q4 		$1.6M Buy
+24,367
New +$1.31M ﹤0.01% 1041
2015
Q3 		– Sell
-23,980
Closed -$1.96M – 1361
2015
Q2 		$1.96M Buy
23,980
+6,756
+39% +$661K ﹤0.01% 1030
2015
Q1 		$1.59M Buy
+17,224
New +$1.11M ﹤0.01% 1081

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

American Century Companies's ESPR Position: Q3 2024 in Review

American Century Companies sold out of Esperion Therapeutics (ESPR) in Q3 2024, closing a stake of 22,518 shares — an estimated $50K sold.

American Century Companies first reported a position in ESPR in Q1 2015 and held it in 13 quarters. The position peaked at $2.89M in Q3 2019. 183 funds tracked by Wall St. Rank hold ESPR as of Q3 2024.

  • American Century Companies reported no remaining Esperion Therapeutics position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 22,518 Esperion Therapeutics shares in Q3 2024, an estimated $50K.
  • American Century Companies first reported a position in Esperion Therapeutics in Q1 2015 and held it in 13 quarters.
  • American Century Companies's Esperion Therapeutics position peaked at $2.89M in Q3 2019.
  • 183 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.